Skip to content

Targeting a human protein to squash SARS-CoV-2 and other viruses

  • by
  • blog
  • 1 min read

Scientists report that apratoxin S4, an anticancer drug candidate that targets a human protein, can interfere with the replication of many viruses, including SARS-CoV-2 and influenza A, offering a possible pan-viral therapy.


Join the conversation

Your email address will not be published. Required fields are marked *